Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Prospector who wrote (1132)	6/18/1998 10:29:00 AM
From: eRM Solutions	Read Replies (1) \| Respond to of 5402

Prospector, Say that when the rest of the Posse arrives. BTW, that was civil.

To: Prospector who wrote (1132)	6/18/1998 10:36:00 AM
From: Gwolf	Read Replies (1) \| Respond to of 5402

Let's see the Japanese falsified documents as to the original date that the product was given to a human, so the Japanese FDA asked the company to stop selling the drug until they could investigate. The Japanese owners lost face and also removed the product from the US market. The United States FDA approved the product and never requested that it be removed from the market. The original product still has FDA approval to THIS VERY DAY. Some people get real confused when you present them with facts.The company now has funding for the animal trials which should cost approximately $300,000.00. Once it receives FDA approval for animals we then go to the human testing. I wonder if the MM's still use third parties to disseminate erroneous information to the public. I wonder if the SEC investigation into manipulative MM's practices is going on. Makes you go Huuuummmmmmmmmmmmmmmm ???????????? Gwolf